Which has higher earnings and valuation, ELMD or IRMD?

iRadimed has higher revenue and earnings than Electromed. Electromed is trading at a lower price-to-earnings ratio than iRadimed, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Electromed $71.75M 4.35 $5.15M $1.17 32.24 iRadimed $86.28M 13.43 $22.48M $1.83 49.54

Is ELMD or IRMD more profitable?

iRadimed has a net margin of 27.36% compared to Electromed's net margin of 11.34%. iRadimed's return on equity of 24.48% beat Electromed's return on equity. Company Net Margins Return on Equity Return on Assets Electromed 11.34% 15.71% 13.37% iRadimed 27.36% 24.48% 21.25%

Do analysts recommend ELMD or AVNS?

Electromed presently has a consensus price target of $37.50, indicating a potential downside of 0.58%. Given Electromed's stronger consensus rating and higher possible upside, analysts clearly believe Electromed is more favorable than Avanos Medical. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Electromed 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 1 Strong Buy rating(s) 3.25 Avanos Medical 2 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Electromed (ELMD) Competitors

$37.72 -1.57 (-4.00%)

Closing price 05/29/2026 04:00 PM Eastern

Extended Trading

$37.65 -0.07 (-0.20%)

As of 05/29/2026 05:41 PM Eastern

Compare

ELMD vs. INSP, IRMD, AVNS, BLFS, and BFLY

Should you buy Electromed stock or one of its competitors? MarketBeat compares Electromed with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Electromed include Inspire Medical Systems (INSP), iRadimed (IRMD), Avanos Medical (AVNS), BioLife Solutions (BLFS), and Butterfly Network (BFLY). These companies are all part of the "medical equipment" industry.

How does Electromed compare to Inspire Medical Systems?

Inspire Medical Systems (NYSE:INSP) and Electromed (NYSE:ELMD) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, risk, dividends, valuation, media sentiment, earnings, analyst recommendations and profitability.

Inspire Medical Systems has higher revenue and earnings than Electromed. Inspire Medical Systems is trading at a lower price-to-earnings ratio than Electromed, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Inspire Medical Systems	$915.25M	1.31	$145.42M	$4.49	9.23
Electromed	$71.75M	4.35	$5.15M	$1.17	32.24

Inspire Medical Systems has a net margin of 14.33% compared to Electromed's net margin of 11.34%. Electromed's return on equity of 15.71% beat Inspire Medical Systems' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Inspire Medical Systems	14.33%	10.35%	8.81%
Electromed	11.34%	15.71%	13.37%

Inspire Medical Systems has a beta of 0.83, suggesting that its stock price is 17% less volatile than the broader market. Comparatively, Electromed has a beta of 0.39, suggesting that its stock price is 61% less volatile than the broader market.

Inspire Medical Systems presently has a consensus target price of $81.84, suggesting a potential upside of 97.40%. Electromed has a consensus target price of $37.50, suggesting a potential downside of 0.58%. Given Inspire Medical Systems' higher possible upside, equities analysts clearly believe Inspire Medical Systems is more favorable than Electromed.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Inspire Medical Systems	3 Sell rating(s)	13 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.05
Electromed	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	3.25

In the previous week, Inspire Medical Systems had 3 more articles in the media than Electromed. MarketBeat recorded 3 mentions for Inspire Medical Systems and 0 mentions for Electromed. Electromed's average media sentiment score of 0.00 beat Inspire Medical Systems' score of -0.10 indicating that Electromed is being referred to more favorably in the news media.

Company	Overall Sentiment
Inspire Medical Systems	Neutral
Electromed	Neutral

94.9% of Inspire Medical Systems shares are held by institutional investors. Comparatively, 40.8% of Electromed shares are held by institutional investors. 2.2% of Inspire Medical Systems shares are held by company insiders. Comparatively, 10.5% of Electromed shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Summary

Inspire Medical Systems beats Electromed on 9 of the 17 factors compared between the two stocks.

How does Electromed compare to iRadimed?

Electromed (NYSE:ELMD) and iRadimed (NASDAQ:IRMD) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their analyst recommendations, profitability, media sentiment, dividends, risk, valuation, earnings and institutional ownership.

In the previous week, iRadimed had 5 more articles in the media than Electromed. MarketBeat recorded 5 mentions for iRadimed and 0 mentions for Electromed. iRadimed's average media sentiment score of 0.42 beat Electromed's score of 0.00 indicating that iRadimed is being referred to more favorably in the news media.

Company	Overall Sentiment
Electromed	Neutral
iRadimed	Neutral

Electromed has a beta of 0.39, indicating that its stock price is 61% less volatile than the broader market. Comparatively, iRadimed has a beta of 0.9, indicating that its stock price is 10% less volatile than the broader market.

iRadimed has higher revenue and earnings than Electromed. Electromed is trading at a lower price-to-earnings ratio than iRadimed, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Electromed	$71.75M	4.35	$5.15M	$1.17	32.24
iRadimed	$86.28M	13.43	$22.48M	$1.83	49.54

40.8% of Electromed shares are held by institutional investors. Comparatively, 92.3% of iRadimed shares are held by institutional investors. 10.5% of Electromed shares are held by insiders. Comparatively, 36.8% of iRadimed shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Electromed presently has a consensus target price of $37.50, suggesting a potential downside of 0.58%. iRadimed has a consensus target price of $120.00, suggesting a potential upside of 32.36%. Given iRadimed's higher possible upside, analysts plainly believe iRadimed is more favorable than Electromed.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Electromed	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	3.25
iRadimed	0 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	3.00

iRadimed has a net margin of 27.36% compared to Electromed's net margin of 11.34%. iRadimed's return on equity of 24.48% beat Electromed's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Electromed	11.34%	15.71%	13.37%
iRadimed	27.36%	24.48%	21.25%

Summary

iRadimed beats Electromed on 13 of the 15 factors compared between the two stocks.

How does Electromed compare to Avanos Medical?

Electromed (NYSE:ELMD) and Avanos Medical (NYSE:AVNS) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their risk, earnings, media sentiment, dividends, analyst recommendations, institutional ownership, valuation and profitability.

Electromed presently has a consensus price target of $37.50, indicating a potential downside of 0.58%. Given Electromed's stronger consensus rating and higher possible upside, analysts clearly believe Electromed is more favorable than Avanos Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Electromed	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	3.25
Avanos Medical	2 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

40.8% of Electromed shares are held by institutional investors. Comparatively, 95.2% of Avanos Medical shares are held by institutional investors. 10.5% of Electromed shares are held by company insiders. Comparatively, 2.3% of Avanos Medical shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Electromed has a beta of 0.39, suggesting that its share price is 61% less volatile than the broader market. Comparatively, Avanos Medical has a beta of 1.58, suggesting that its share price is 58% more volatile than the broader market.

Electromed has a net margin of 11.34% compared to Avanos Medical's net margin of -10.39%. Electromed's return on equity of 15.71% beat Avanos Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Electromed	11.34%	15.71%	13.37%
Avanos Medical	-10.39%	5.39%	3.97%

Electromed has higher earnings, but lower revenue than Avanos Medical. Avanos Medical is trading at a lower price-to-earnings ratio than Electromed, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Electromed	$71.75M	4.35	$5.15M	$1.17	32.24
Avanos Medical	$715.90M	1.62	-$72.90M	-$1.61	N/A

In the previous week, Avanos Medical had 3 more articles in the media than Electromed. MarketBeat recorded 3 mentions for Avanos Medical and 0 mentions for Electromed. Avanos Medical's average media sentiment score of 0.33 beat Electromed's score of 0.00 indicating that Avanos Medical is being referred to more favorably in the news media.

Company	Overall Sentiment
Electromed	Neutral
Avanos Medical	Neutral

Summary

Electromed beats Avanos Medical on 12 of the 17 factors compared between the two stocks.

How does Electromed compare to BioLife Solutions?

BioLife Solutions (NASDAQ:BLFS) and Electromed (NYSE:ELMD) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, earnings, institutional ownership, media sentiment, valuation, risk, analyst recommendations and dividends.

BioLife Solutions presently has a consensus target price of $32.00, suggesting a potential upside of 28.41%. Electromed has a consensus target price of $37.50, suggesting a potential downside of 0.58%. Given BioLife Solutions' higher probable upside, research analysts clearly believe BioLife Solutions is more favorable than Electromed.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
BioLife Solutions	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
Electromed	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	3.25

93.2% of BioLife Solutions shares are held by institutional investors. Comparatively, 40.8% of Electromed shares are held by institutional investors. 2.2% of BioLife Solutions shares are held by company insiders. Comparatively, 10.5% of Electromed shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Electromed has a net margin of 11.34% compared to BioLife Solutions' net margin of -2.80%. Electromed's return on equity of 15.71% beat BioLife Solutions' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
BioLife Solutions	-2.80%	1.81%	1.65%
Electromed	11.34%	15.71%	13.37%

In the previous week, BioLife Solutions had 3 more articles in the media than Electromed. MarketBeat recorded 3 mentions for BioLife Solutions and 0 mentions for Electromed. BioLife Solutions' average media sentiment score of 0.81 beat Electromed's score of 0.00 indicating that BioLife Solutions is being referred to more favorably in the media.

Company	Overall Sentiment
BioLife Solutions	Positive
Electromed	Neutral

Electromed has lower revenue, but higher earnings than BioLife Solutions. BioLife Solutions is trading at a lower price-to-earnings ratio than Electromed, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
BioLife Solutions	$96.21M	12.66	-$4.59M	-$0.08	N/A
Electromed	$71.75M	4.35	$5.15M	$1.17	32.24

BioLife Solutions has a beta of 1.97, indicating that its share price is 97% more volatile than the broader market. Comparatively, Electromed has a beta of 0.39, indicating that its share price is 61% less volatile than the broader market.

Summary

Electromed beats BioLife Solutions on 9 of the 16 factors compared between the two stocks.

How does Electromed compare to Butterfly Network?

Butterfly Network (NYSE:BFLY) and Electromed (NYSE:ELMD) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, analyst recommendations, earnings, risk, profitability, institutional ownership, dividends and valuation.

Electromed has lower revenue, but higher earnings than Butterfly Network. Butterfly Network is trading at a lower price-to-earnings ratio than Electromed, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Butterfly Network	$102.92M	11.12	-$77.06M	-$0.30	N/A
Electromed	$71.75M	4.35	$5.15M	$1.17	32.24

Electromed has a net margin of 11.34% compared to Butterfly Network's net margin of -73.63%. Electromed's return on equity of 15.71% beat Butterfly Network's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Butterfly Network	-73.63%	-34.41%	-23.91%
Electromed	11.34%	15.71%	13.37%

37.8% of Butterfly Network shares are owned by institutional investors. Comparatively, 40.8% of Electromed shares are owned by institutional investors. 25.2% of Butterfly Network shares are owned by insiders. Comparatively, 10.5% of Electromed shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Butterfly Network has a beta of 2.27, indicating that its stock price is 127% more volatile than the broader market. Comparatively, Electromed has a beta of 0.39, indicating that its stock price is 61% less volatile than the broader market.

In the previous week, Butterfly Network's average media sentiment score of 1.00 beat Electromed's score of 0.00 indicating that Butterfly Network is being referred to more favorably in the media.

Company	Overall Sentiment
Butterfly Network	Positive
Electromed	Neutral

Butterfly Network presently has a consensus price target of $5.56, indicating a potential upside of 23.75%. Electromed has a consensus price target of $37.50, indicating a potential downside of 0.58%. Given Butterfly Network's higher probable upside, equities analysts plainly believe Butterfly Network is more favorable than Electromed.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Butterfly Network	1 Sell rating(s)	2 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.33
Electromed	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	3.25

Summary

Electromed beats Butterfly Network on 9 of the 15 factors compared between the two stocks.

Get Electromed News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ELMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ELMD vs. The Competition

Export

Metric	Electromed	Electromedical equipment Industry	Medical Sector	NYSE Exchange
Market Cap	$312.32M	$77.15M	$6.45B	$23.14B
Dividend Yield	N/A	N/A	2.69%	4.07%
P/E Ratio	50.29	8.39	21.38	30.63
Price / Sales	4.35	193.59	530.78	85.39
Price / Cash	41.36	41.36	43.65	25.11
Price / Book	7.40	7.78	10.60	4.79
Net Income	$5.15M	-$5.50M	$3.56B	$1.07B
7 Day Performance	-1.31%	-0.37%	2.83%	1.14%
1 Month Performance	46.71%	10.91%	4.57%	1.26%
1 Year Performance	86.73%	188.20%	37.66%	27.95%

Electromed Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ELMD Electromed	0.6914 of 5 stars	$37.72 -4.0%	$37.50 -0.6%	+84.8%	$312.32M	$71.75M	50.29	160
INSP Inspire Medical Systems	3.9733 of 5 stars	$43.09 -1.7%	$81.84 +89.9%	-69.9%	$1.24B	$911.98M	9.60	1,333
IRMD iRadimed	2.9215 of 5 stars	$92.83 +0.8%	$120.00 +29.3%	+55.9%	$1.19B	$83.81M	50.73	110
AVNS Avanos Medical	0.8563 of 5 stars	$24.70 +0.4%	N/A	+96.6%	$1.16B	$701.20M	N/A	2,287	Analyst Revision
BLFS BioLife Solutions	2.8088 of 5 stars	$23.62 -1.4%	$32.00 +35.5%	+11.6%	$1.15B	$96.21M	N/A	440	Analyst Revision

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:ELMD) was last updated on 5/30/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Electromed (ELMD) Competitors

ELMD vs. INSP, IRMD, AVNS, BLFS, and BFLY

How does Electromed compare to Inspire Medical Systems?

Summary

How does Electromed compare to iRadimed?

Summary

How does Electromed compare to Avanos Medical?

Summary

How does Electromed compare to BioLife Solutions?

Summary

How does Electromed compare to Butterfly Network?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ELMD vs. The Competition

Electromed Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Electromed (ELMD) Competitors

ELMD vs. INSP, IRMD, AVNS, BLFS, and BFLY

How does Electromed compare to Inspire Medical Systems?

Which has higher valuation and earnings, INSP or ELMD?

Is INSP or ELMD more profitable?

Which has more risk & volatility, INSP or ELMD?

Do analysts prefer INSP or ELMD?

Does the media prefer INSP or ELMD?

Do institutionals and insiders have more ownership in INSP or ELMD?

Summary

How does Electromed compare to iRadimed?

Does the media refer more to ELMD or IRMD?

Which has more risk and volatility, ELMD or IRMD?

Which has higher earnings and valuation, ELMD or IRMD?

Do insiders & institutionals hold more shares of ELMD or IRMD?

Do analysts prefer ELMD or IRMD?

Is ELMD or IRMD more profitable?

Summary

How does Electromed compare to Avanos Medical?

Do analysts recommend ELMD or AVNS?

Do institutionals & insiders believe in ELMD or AVNS?

Which has more risk and volatility, ELMD or AVNS?

Is ELMD or AVNS more profitable?

Which has preferable valuation and earnings, ELMD or AVNS?

Does the media refer more to ELMD or AVNS?

Summary

How does Electromed compare to BioLife Solutions?

Do analysts recommend BLFS or ELMD?

Do insiders & institutionals have more ownership in BLFS or ELMD?

Is BLFS or ELMD more profitable?

Does the media favor BLFS or ELMD?

Which has higher valuation & earnings, BLFS or ELMD?

Which has more volatility and risk, BLFS or ELMD?

Summary

How does Electromed compare to Butterfly Network?

Which has stronger earnings and valuation, BFLY or ELMD?

Is BFLY or ELMD more profitable?

Do insiders & institutionals believe in BFLY or ELMD?

Which has more volatility and risk, BFLY or ELMD?

Does the media favor BFLY or ELMD?

Do analysts recommend BFLY or ELMD?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ELMD vs. The Competition

Electromed Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools